Cargando…
Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis
BACKGROUND: Non-cardiovascular chest pain (NCCP) has a high healthcare cost, but insufficient guidelines exist for its diagnostic investigation. The objective of the present work was to identify important diagnostic indicators and their accuracy for specific and non-specific conditions underlying NC...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226211/ https://www.ncbi.nlm.nih.gov/pubmed/24207111 http://dx.doi.org/10.1186/1741-7015-11-239 |
_version_ | 1782343598133477376 |
---|---|
author | Wertli, Maria M Ruchti, Katrin B Steurer, Johann Held, Ulrike |
author_facet | Wertli, Maria M Ruchti, Katrin B Steurer, Johann Held, Ulrike |
author_sort | Wertli, Maria M |
collection | PubMed |
description | BACKGROUND: Non-cardiovascular chest pain (NCCP) has a high healthcare cost, but insufficient guidelines exist for its diagnostic investigation. The objective of the present work was to identify important diagnostic indicators and their accuracy for specific and non-specific conditions underlying NCCP. METHODS: A systematic review and meta-analysis were performed. In May 2012, six databases were searched. Hand and bibliography searches were also conducted. Studies evaluating a diagnostic test against a reference test in patients with NCCP were included. Exclusion criteria were having <30 patients per group, and evaluating diagnostic tests for acute cardiovascular disease. Diagnostic accuracy is given in likelihood ratios (LR): very good (LR+ >10, LR- <0.1); good (LR + 5 to 10, LR- 0.1 to 0.2); fair (LR + 2 to 5, LR- 0.2 to 0.5); or poor (LR + 1 to 2, LR- 0.5 to 1). Joined meta-analysis of the diagnostic test sensitivity and specificity was performed by applying a hierarchical Bayesian model. RESULTS: Out of 6,316 records, 260 were reviewed in full text, and 28 were included: 20 investigating gastroesophageal reflux disorders (GERD), 3 musculoskeletal chest pain, and 5 psychiatric conditions. Study quality was good in 15 studies and moderate in 13. GERD diagnosis was more likely with typical GERD symptoms (LR + 2.70 and 2.75, LR- 0.42 and 0.78) than atypical GERD symptoms (LR + 0.49, LR- 2.71). GERD was also more likely with a positive response to a proton pump inhibitor (PPI) test (LR + 5.48, 7.13, and 8.56; LR- 0.24, 0.25, and 0.28); the posterior mean sensitivity and specificity of six studies were 0.89 (95% credible interval, 0.28 to 1) and 0.88 (95% credible interval, 0.26 to 1), respectively. Panic and anxiety screening scores can identify individuals requiring further testing for anxiety or panic disorders. Clinical findings in musculoskeletal pain either had a fair to moderate LR + and a poor LR- or vice versa. CONCLUSIONS: In patients with NCCP, thorough clinical evaluation of the patient’s history, symptoms, and clinical findings can indicate the most appropriate diagnostic tests. Treatment response to high-dose PPI treatment provides important information regarding GERD, and should be considered early. Panic and anxiety disorders are often undiagnosed and should be considered in the differential diagnosis of chest pain. |
format | Online Article Text |
id | pubmed-4226211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42262112014-11-11 Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis Wertli, Maria M Ruchti, Katrin B Steurer, Johann Held, Ulrike BMC Med Research Article BACKGROUND: Non-cardiovascular chest pain (NCCP) has a high healthcare cost, but insufficient guidelines exist for its diagnostic investigation. The objective of the present work was to identify important diagnostic indicators and their accuracy for specific and non-specific conditions underlying NCCP. METHODS: A systematic review and meta-analysis were performed. In May 2012, six databases were searched. Hand and bibliography searches were also conducted. Studies evaluating a diagnostic test against a reference test in patients with NCCP were included. Exclusion criteria were having <30 patients per group, and evaluating diagnostic tests for acute cardiovascular disease. Diagnostic accuracy is given in likelihood ratios (LR): very good (LR+ >10, LR- <0.1); good (LR + 5 to 10, LR- 0.1 to 0.2); fair (LR + 2 to 5, LR- 0.2 to 0.5); or poor (LR + 1 to 2, LR- 0.5 to 1). Joined meta-analysis of the diagnostic test sensitivity and specificity was performed by applying a hierarchical Bayesian model. RESULTS: Out of 6,316 records, 260 were reviewed in full text, and 28 were included: 20 investigating gastroesophageal reflux disorders (GERD), 3 musculoskeletal chest pain, and 5 psychiatric conditions. Study quality was good in 15 studies and moderate in 13. GERD diagnosis was more likely with typical GERD symptoms (LR + 2.70 and 2.75, LR- 0.42 and 0.78) than atypical GERD symptoms (LR + 0.49, LR- 2.71). GERD was also more likely with a positive response to a proton pump inhibitor (PPI) test (LR + 5.48, 7.13, and 8.56; LR- 0.24, 0.25, and 0.28); the posterior mean sensitivity and specificity of six studies were 0.89 (95% credible interval, 0.28 to 1) and 0.88 (95% credible interval, 0.26 to 1), respectively. Panic and anxiety screening scores can identify individuals requiring further testing for anxiety or panic disorders. Clinical findings in musculoskeletal pain either had a fair to moderate LR + and a poor LR- or vice versa. CONCLUSIONS: In patients with NCCP, thorough clinical evaluation of the patient’s history, symptoms, and clinical findings can indicate the most appropriate diagnostic tests. Treatment response to high-dose PPI treatment provides important information regarding GERD, and should be considered early. Panic and anxiety disorders are often undiagnosed and should be considered in the differential diagnosis of chest pain. BioMed Central 2013-11-08 /pmc/articles/PMC4226211/ /pubmed/24207111 http://dx.doi.org/10.1186/1741-7015-11-239 Text en Copyright © 2013 Wertli et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wertli, Maria M Ruchti, Katrin B Steurer, Johann Held, Ulrike Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title_full | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title_fullStr | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title_full_unstemmed | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title_short | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
title_sort | diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226211/ https://www.ncbi.nlm.nih.gov/pubmed/24207111 http://dx.doi.org/10.1186/1741-7015-11-239 |
work_keys_str_mv | AT wertlimariam diagnosticindicatorsofnoncardiovascularchestpainasystematicreviewandmetaanalysis AT ruchtikatrinb diagnosticindicatorsofnoncardiovascularchestpainasystematicreviewandmetaanalysis AT steurerjohann diagnosticindicatorsofnoncardiovascularchestpainasystematicreviewandmetaanalysis AT heldulrike diagnosticindicatorsofnoncardiovascularchestpainasystematicreviewandmetaanalysis |